Brief: Aarti Drugs Receives Administrative Warning Letter From SEBI
07/03/2025 07:34
March 7 (Reuters) - Aarti Drugs Ltd ADRG.NS: AARTI DRUGS LTD - RECEIVES ADMINISTRATIVE WARNING LETTER FROM SEBI AARTI DRUGS LTD - WARNING ISSUED FOR VIOLATION OF INSIDER TRADING REGULATIONS Source text: ID:nBSE2bv5vK Further company coverage: ADRG.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees